Using the Chinese Indigenization FS Scale in the Diagnosis of Fibromyalgia: Specificity and Sensitivity in Clinical Practice

ConditionFibromyalgia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGuang'anmen Hospital of China Academy of Chinese Medical Sciences

About this trial

This study aimed to evaluate the specificity and sensitivity of the diagnostic criteria for fibromyalgia after conducting local validation in China.

Eligibility criteria

Qualifiers

At least 18 years of age; Patients with chronic widespread pain; Able to complete the questionnaire.

Disqualifiers

Terminal patients with severe psychiatric diseases, tumors, systemic lupus erythematosus, systemic sclerosis, or other serious diseases.

Trial design

Treatments tested in this trial

  • The FM Diagnosis and Assessment Scale will be filled out, and there will be no other interventions beyond that

Treatment groups

59 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Lead sponsor

Hebei Provincial Hospital of Traditional Chinese Medicine

Collaborator

BAODING NO.1 HOSPITAL OF TCM

Collaborator

Inner Mongolia Hospital of Traditional Chinese Medicine

Collaborator

Shenzhen Hospital of Traditional Chinese Medicine

Collaborator

Suzhou Hospital of Traditional Chinese Medicine

Collaborator